BA
47
2
PVH
60
-4
WDC
37
-3
ADM
28
3
SBUX
37
-2
CSX
57
-4
AN
50
-5
NI
72
4
STX
45
-4
HSY
31
-6
AMAT
33
-13
ETN
75
-3
CTSH
60
-3
F
56
-3
BMY
55
-8
CVS
41
-4
SIG
44
-3
XOM
42
-6
LLY
28
-8
SCHW
62
-2
BA
47
2
PVH
60
-4
WDC
37
-3
ADM
28
3
SBUX
37
-2
CSX
57
-4
AN
50
-5
NI
72
4
STX
45
-4
HSY
31
-6
AMAT
33
-13
ETN
75
-3
CTSH
60
-3
F
56
-3
BMY
55
-8
CVS
41
-4
SIG
44
-3
XOM
42
-6
LLY
28
-8
SCHW
62
-2
Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Repligen Industry Stock Comparison

Buy
58

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
17.67
Seasonality Move:
-11.71%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Buy
58
ProShares UltraShort Nasdaq Biotech (BIS) is a Buy

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.68. The Score for BIS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $17.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 73.3 Buy
Chaikin Money Flow: 42987 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.61 - 15.95) Buy
Bollinger Bands (100): (14.52 - 15.96) Buy

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.36 Buy
20-day SMA: 15.4 Buy
50-day SMA: 15.19 Buy
200-day SMA: 16.65 Buy
8-day EMA: 15.84 Buy
20-day EMA: 15.46 Buy
50-day EMA: 15.33 Buy
200-day EMA: 16.63 Buy

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):